Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

OnCore Login
Login to Oncore Network

Login to Oncore Network

Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

Community Health Network, Inc. Cancer Centers

1500 North Ritter Ave, Room 1508, Indianapolis, IN 46219 - USA

Community Health Network, Inc. Cancer Centers provide Central Indiana patients with surgical options, radiation therapy, medical oncology, integrative medicine, and survivor support through their network of certified cancer specialists. Community Health Network Cancer Centers are dedicated to providing a comprehensive and integrated cancer care program that will enable patients and their families to receive a full continuum of services—from early detection and screening through the latest treatment options.

Community Health Network, Inc. is an affiliate of MD Anderson Cancer Network, a program of The University of Texas MD Anderson Cancer Center. This collaboration provides certified physicians at these two Community hospitals with access to evidence-based guidelines, treatment plans, and concordance studies developed by MD Anderson experts. MD Anderson has ranked number one in cancer care in the “Best Hospitals” survey published by U.S. News & World Report numerous times.

Website: Community Regional Cancer Centers

Contact:
Kelly Verel
317-497-2836

Trials at this location:

LUN15-233

Randomized Phase II Trial of Docetaxel plus Nivolumab or Docetaxel alone in patients with advanced non-squamous NSCLC and previous clinical benefit on treatment with single agent Nivolumab.

Status: Open to Accrual
Read More

GU14-188

Phase Ib/II Study of Neoadjuvant Pembrolizumab With Gemcitabine-Cisplatin (Cisplatin-Eligible) or Gemcitabine (Cisplatin-Ineligible) in Subjects With T2-4aN0M0 Urothelial Cancer: HCRN GU14-188

Status: Open to Accrual
Read More

GU14-182

A Randomized, Double-Blinded, Phase II Study of Maintenance Pembrolizumab versus Placebo after First-line Chemotherapy in Patients with Metastatic Urothelial Cancer: HCRN GU14-182

Status: Open to Accrual
Read More

BRE12-158

A Phase II Randomized Controlled Trial of Genomically Directed Therapy After Preoperative Chemotherapy in Patients with Triple Negative Breast Cancer.

Status: Open to Accrual
Read More